---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-025435"
form_type: "8-K"
ticker: "DARE"
cik: "0001401914"
company_name: "Dare Bioscience, Inc."
filed_at: "2024-06-27T23:59:59+00:00"
generated_at: "2026-06-01T00:58:26.762423+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Daré Bioscience announces 1-for-12 reverse stock split effective July 1, 2024 to regain Nasdaq compliance

## Summary
- 1-for-12 reverse stock split effective July 1, 2024; shares reduce from ~101.1M to ~8.4M.
- Purpose: regain compliance with Nasdaq $1.00 minimum bid price requirement.
- Stockholder authorization obtained at June 5, 2024 annual meeting; Board set ratio at 1-for-12.
- No fractional shares issued; fractional interests rounded up to next whole share after aggregation.
- New CUSIP 23666P200; stock continues trading as DARE on Nasdaq.

## SEC filing metadata
- accession: 0001493152-24-025435
- form_type: 8-K
- ticker: DARE
- cik: 0001401914
- company_name: Dare Bioscience, Inc.
- filed_at: 2024-06-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.03, 5.03, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1401914/000149315224025435/0001493152-24-025435-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1401914/000149315224025435/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-025435
- JSON: https://secwatch.observer/filing/0001493152-24-025435.json
- Plain text: https://secwatch.observer/filing/0001493152-24-025435.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.